Smith+Nephew is a global medical technology company specializing in the repair, regeneration, and replacement of tissue and bone. With operations in more than 100 countries, the company focuses on delivering advanced solutions in orthopaedics, sports medicine, ENT (ear, nose, and throat), and wound care management. Smith+Nephew's innovative product portfolio supports faster healing, improved outcomes, and enhanced mobility for patients. By investing in minimally invasive technologies and smart surgical systems, it empowers medical professionals to improve patient recovery and quality of life.
Smith+Nephew demonstrates integrated robotic surgical platforms and high-porosity biological implants designed to improve biomechanical load distribution in joint repair procedures.
With De Novo classification, the TESSA System serves as the first device in a new FDA category for intra-articular orthopedic stereotaxic navigation instruments.
Smith+Nephew has launched a multi-purpose surgical wand utilizing low-temperature radiofrequency technology to streamline airway procedures from the supraglottis to the trachea.
CORI XT Handheld Robotic Platform is designed to be the single handheld robotics platform for all orthopedic needs - partial to revision knee, hip, and anatomic and reverse shoulders.
The partnership with RMR Ortho adds a dynamic nitinol fixation solution to Smith & Nephew’s portfolio, enhancing surgical options for fracture and fusion procedures.